PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,875 Cr | ₹3,851 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹4,875 Cr |
| Mar2025 | ₹3,851 Cr |
| Mar2024 | ₹4,369 Cr |
| Mar2023 | ₹3,851 Cr |
| Mar2022 | ₹3,118 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,875 Cr | 26.60 | |
| Mar2025 | ₹3,851 Cr | -11.87 | |
| Mar2024 | ₹4,369 Cr | 13.46 | |
| Mar2023 | ₹3,851 Cr | 23.51 | |
| Mar2022 | ₹3,118 Cr | - | |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,885.0 Cr | -2.3% | 1.8% | -17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -2.3% |
1.8% |
-17.7% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses